<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns="http://purl.org/rss/1.0/">
<channel rdf:about="http://www.nature.com/bjp/journal/vaop/ncurrent/rss.rdf">
<title>British Journal of Pharmacology</title>
<description/>
<link>http://www.nature.com/bjp/journal/vaop/ncurrent/rss.rdf</link>
<dc:publisher>Nature Publishing Group</dc:publisher>
<dc:language>en</dc:language>
<dc:rights>
Copyright &#169;  Nature Publishing Group</dc:rights>
<prism:publicationName>British Journal of Pharmacology</prism:publicationName>
<prism:issn>0007-1188</prism:issn>
<prism:copyright>
Copyright &#169;  Nature Publishing Group</prism:copyright>
<prism:rightsAgent>permissions@nature.com</prism:rightsAgent>
<image rdf:resource="http://www.nature.com/aj/images/logos_b_o_w/bjp.gif"/>
<items>
<rdf:Seq>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/bjp.2008.366"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/bjp.2008.183"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/bjp.2008.339"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/bjp.2008.346"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/bjp.2008.348"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/bjp.2008.352"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/bjp.2008.372"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/bjp.2008.345"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/bjp.2008.334"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/bjp.2008.354"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/bjp.2008.327"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/bjp.2008.374"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/bjp.2008.347"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/bjp.2008.365"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/bjp.2008.330"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/bjp.2008.341"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/bjp.2008.370"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/bjp.2008.363"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/bjp.2008.332"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/bjp.2008.343"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/bjp.2008.369"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/bjp.2008.367"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/bjp.2008.356"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/bjp.2008.349"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/bjp.2008.358"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/bjp.2008.373"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/bjp.2008.360"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/bjp.2008.335"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/bjp.2008.355"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/bjp.2008.375"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/bjp.2008.344"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/bjp.2008.337"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/bjp.2008.357"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/bjp.2008.326"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/bjp.2008.351"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/bjp.2008.371"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/bjp.2008.340"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/bjp.2008.353"/>
</rdf:Seq>
</items>
</channel>
<image rdf:about="http://www.nature.com/aj/images/logos_b_o_w/bjp.gif">
<title>British Journal of Pharmacology</title>
<url>http://www.nature.com/aj/images/logos_b_o_w/bjp.gif</url>
<link>http://www.nature.com/bjp/</link>
</image>
<item rdf:about="http://dx.doi.org/10.1038/bjp.2008.366">
<title>Impact of efflux transporters and of seizures on the pharmacokinetics of oxcarbazepine metabolite in the rat brain</title>
<link>http://dx.doi.org/10.1038/bjp.2008.366</link>
<content:encoded><![CDATA[

<p>
<b>Impact of efflux transporters and of seizures on the pharmacokinetics of oxcarbazepine metabolite in the rat brain</b>
</p>
<p>British Journal of Pharmacology advance online publication, October 6, 2008. <a href="http://dx.doi.org/10.1038/bjp.2008.366">doi:10.1038/bjp.2008.366</a>
</p>
<p>Authors: R Clinckers, I Smolders, Y Michotte, G Ebinger, M Danhof, R A Voskuyl
&amp; O Della Pasqua</p>
]]></content:encoded>
<dc:title>Impact of efflux transporters and of seizures on the pharmacokinetics of oxcarbazepine metabolite in the rat brain</dc:title>
<dc:creator>R Clinckers</dc:creator>
<dc:creator>I Smolders</dc:creator>
<dc:creator>Y Michotte</dc:creator>
<dc:creator>G Ebinger</dc:creator>
<dc:creator>M Danhof</dc:creator>
<dc:creator>R A Voskuyl</dc:creator>
<dc:creator>O Della Pasqua</dc:creator>
<dc:identifier>doi:10.1038/bjp.2008.366</dc:identifier>
<dc:source>British Journal of Pharmacology advance online publication, October 6, 2008</dc:source>
<dc:date>October 6, 2008</dc:date>
<prism:publicationName>British Journal of Pharmacology</prism:publicationName>
<prism:publicationDate>October 6, 2008</prism:publicationDate>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/bjp.2008.183">
<title>Retraction: Sex differences in the expression of sodium&#47;calcium exchanger influence the arrhythmia phenotype in the long QT syndrome type 2</title>
<link>http://dx.doi.org/10.1038/bjp.2008.183</link>
<content:encoded><![CDATA[

<p>
<b>Retraction: Sex differences in the expression of sodium&#47;calcium exchanger influence the arrhythmia phenotype in the long QT syndrome type 2</b>
</p>
<p>British Journal of Pharmacology advance online publication, May 19, 2008. <a href="http://dx.doi.org/10.1038/bjp.2008.183">doi:10.1038/bjp.2008.183</a>
</p>
<p>Authors: G Salama, B London, L J Kerchner, N R Salama
&amp; T Liu</p>
]]></content:encoded>
<dc:title>Retraction: Sex differences in the expression of sodium&#47;calcium exchanger influence the arrhythmia phenotype in the long QT syndrome type 2</dc:title>
<dc:creator>G Salama</dc:creator>
<dc:creator>B London</dc:creator>
<dc:creator>L J Kerchner</dc:creator>
<dc:creator>N R Salama</dc:creator>
<dc:creator>T Liu</dc:creator>
<dc:identifier>doi:10.1038/bjp.2008.183</dc:identifier>
<dc:source>British Journal of Pharmacology advance online publication, May 19, 2008</dc:source>
<dc:date>May 19, 2008</dc:date>
<prism:publicationName>British Journal of Pharmacology</prism:publicationName>
<prism:publicationDate>May 19, 2008</prism:publicationDate>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/bjp.2008.339">
<title>5-HT4-elicited positive inotropic response is mediated by cAMP and regulated by PDE3 in failing rat and human cardiac ventricles</title>
<link>http://dx.doi.org/10.1038/bjp.2008.339</link>
<content:encoded><![CDATA[

<p>
<b>5-HT4-elicited positive inotropic response is mediated by cAMP and regulated by PDE3 in failing rat and human cardiac ventricles</b>
</p>
<p>British Journal of Pharmacology advance online publication, September 1, 2008. <a href="http://dx.doi.org/10.1038/bjp.2008.339">doi:10.1038/bjp.2008.339</a>
</p>
<p>Authors: F Afzal, K W Andressen, H K M&#248;rk, J M Aronsen, I Sjaastad, C P Dahl, T Skomedal, F O Levy, J-B Osnes
&amp; E Qvigstad</p>
]]></content:encoded>
<dc:title>5-HT4-elicited positive inotropic response is mediated by cAMP and regulated by PDE3 in failing rat and human cardiac ventricles</dc:title>
<dc:creator>F Afzal</dc:creator>
<dc:creator>K W Andressen</dc:creator>
<dc:creator>H K M&#248;rk</dc:creator>
<dc:creator>J M Aronsen</dc:creator>
<dc:creator>I Sjaastad</dc:creator>
<dc:creator>C P Dahl</dc:creator>
<dc:creator>T Skomedal</dc:creator>
<dc:creator>F O Levy</dc:creator>
<dc:creator>J-B Osnes</dc:creator>
<dc:creator>E Qvigstad</dc:creator>
<dc:identifier>doi:10.1038/bjp.2008.339</dc:identifier>
<dc:source>British Journal of Pharmacology advance online publication, September 1, 2008</dc:source>
<dc:date>September 1, 2008</dc:date>
<prism:publicationName>British Journal of Pharmacology</prism:publicationName>
<prism:publicationDate>September 1, 2008</prism:publicationDate>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/bjp.2008.346">
<title>CGRP blockers in migraine therapy: where do they act&#63;</title>
<link>http://dx.doi.org/10.1038/bjp.2008.346</link>
<content:encoded><![CDATA[

<p>
<b>CGRP blockers in migraine therapy: where do they act&#63;</b>
</p>
<p>British Journal of Pharmacology advance online publication, September 8, 2008. <a href="http://dx.doi.org/10.1038/bjp.2008.346">doi:10.1038/bjp.2008.346</a>
</p>
<p>Author: L Edvinsson</p>
]]></content:encoded>
<dc:title>CGRP blockers in migraine therapy: where do they act&#63;</dc:title>
<dc:creator>L Edvinsson</dc:creator>
<dc:identifier>doi:10.1038/bjp.2008.346</dc:identifier>
<dc:source>British Journal of Pharmacology advance online publication, September 8, 2008</dc:source>
<dc:date>September 8, 2008</dc:date>
<prism:publicationName>British Journal of Pharmacology</prism:publicationName>
<prism:publicationDate>September 8, 2008</prism:publicationDate>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/bjp.2008.348">
<title>Importance of serum high-density lipoprotein levels to aortic valvular disease</title>
<link>http://dx.doi.org/10.1038/bjp.2008.348</link>
<content:encoded><![CDATA[

<p>
<b>Importance of serum high-density lipoprotein levels to aortic valvular disease</b>
</p>
<p>British Journal of Pharmacology advance online publication, September 1, 2008. <a href="http://dx.doi.org/10.1038/bjp.2008.348">doi:10.1038/bjp.2008.348</a>
</p>
<p>Authors: O C Yontar
&amp; M B Yilmaz</p>
]]></content:encoded>
<dc:title>Importance of serum high-density lipoprotein levels to aortic valvular disease</dc:title>
<dc:creator>O C Yontar</dc:creator>
<dc:creator>M B Yilmaz</dc:creator>
<dc:identifier>doi:10.1038/bjp.2008.348</dc:identifier>
<dc:source>British Journal of Pharmacology advance online publication, September 1, 2008</dc:source>
<dc:date>September 1, 2008</dc:date>
<prism:publicationName>British Journal of Pharmacology</prism:publicationName>
<prism:publicationDate>September 1, 2008</prism:publicationDate>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/bjp.2008.352">
<title>Diastereoselectivity of the P2Y11 nucleotide receptor: mutational analysis</title>
<link>http://dx.doi.org/10.1038/bjp.2008.352</link>
<content:encoded><![CDATA[

<p>
<b>Diastereoselectivity of the P2Y11 nucleotide receptor: mutational analysis</b>
</p>
<p>British Journal of Pharmacology advance online publication, September 29, 2008. <a href="http://dx.doi.org/10.1038/bjp.2008.352">doi:10.1038/bjp.2008.352</a>
</p>
<p>Authors: D Ecke, B Fischer
&amp; G Reiser</p>
]]></content:encoded>
<dc:title>Diastereoselectivity of the P2Y11 nucleotide receptor: mutational analysis</dc:title>
<dc:creator>D Ecke</dc:creator>
<dc:creator>B Fischer</dc:creator>
<dc:creator>G Reiser</dc:creator>
<dc:identifier>doi:10.1038/bjp.2008.352</dc:identifier>
<dc:source>British Journal of Pharmacology advance online publication, September 29, 2008</dc:source>
<dc:date>September 29, 2008</dc:date>
<prism:publicationName>British Journal of Pharmacology</prism:publicationName>
<prism:publicationDate>September 29, 2008</prism:publicationDate>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/bjp.2008.372">
<title>Peroxynitrite: in vivo cardioprotectant or arrhythmogen&#63;</title>
<link>http://dx.doi.org/10.1038/bjp.2008.372</link>
<content:encoded><![CDATA[

<p>
<b>Peroxynitrite: in vivo cardioprotectant or arrhythmogen&#63;</b>
</p>
<p>British Journal of Pharmacology advance online publication, September 22, 2008. <a href="http://dx.doi.org/10.1038/bjp.2008.372">doi:10.1038/bjp.2008.372</a>
</p>
<p>Authors: P Eaton
&amp; H Clements-Jewery</p>
]]></content:encoded>
<dc:title>Peroxynitrite: in vivo cardioprotectant or arrhythmogen&#63;</dc:title>
<dc:creator>P Eaton</dc:creator>
<dc:creator>H Clements-Jewery</dc:creator>
<dc:identifier>doi:10.1038/bjp.2008.372</dc:identifier>
<dc:source>British Journal of Pharmacology advance online publication, September 22, 2008</dc:source>
<dc:date>September 22, 2008</dc:date>
<prism:publicationName>British Journal of Pharmacology</prism:publicationName>
<prism:publicationDate>September 22, 2008</prism:publicationDate>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/bjp.2008.345">
<title>Post-injury baicalein improves histological and functional outcomes and reduces inflammatory cytokines after experimental traumatic brain injury</title>
<link>http://dx.doi.org/10.1038/bjp.2008.345</link>
<content:encoded><![CDATA[

<p>
<b>Post-injury baicalein improves histological and functional outcomes and reduces inflammatory cytokines after experimental traumatic brain injury</b>
</p>
<p>British Journal of Pharmacology advance online publication, September 8, 2008. <a href="http://dx.doi.org/10.1038/bjp.2008.345">doi:10.1038/bjp.2008.345</a>
</p>
<p>Authors: S-F Chen, C-W Hsu, W-H Huang
&amp; J-Y Wang</p>
]]></content:encoded>
<dc:title>Post-injury baicalein improves histological and functional outcomes and reduces inflammatory cytokines after experimental traumatic brain injury</dc:title>
<dc:creator>S-F Chen</dc:creator>
<dc:creator>C-W Hsu</dc:creator>
<dc:creator>W-H Huang</dc:creator>
<dc:creator>J-Y Wang</dc:creator>
<dc:identifier>doi:10.1038/bjp.2008.345</dc:identifier>
<dc:source>British Journal of Pharmacology advance online publication, September 8, 2008</dc:source>
<dc:date>September 8, 2008</dc:date>
<prism:publicationName>British Journal of Pharmacology</prism:publicationName>
<prism:publicationDate>September 8, 2008</prism:publicationDate>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/bjp.2008.334">
<title>CGRP function-blocking antibodies inhibit neurogenic vasodilatation without affecting heart rate or arterial blood pressure in the rat</title>
<link>http://dx.doi.org/10.1038/bjp.2008.334</link>
<content:encoded><![CDATA[

<p>
<b>CGRP function-blocking antibodies inhibit neurogenic vasodilatation without affecting heart rate or arterial blood pressure in the rat</b>
</p>
<p>British Journal of Pharmacology advance online publication, September 8, 2008. <a href="http://dx.doi.org/10.1038/bjp.2008.334">doi:10.1038/bjp.2008.334</a>
</p>
<p>Authors: J Zeller, K T Poulsen, J E Sutton, Y N Abdiche, S Collier, R Chopra, C A Garcia, J Pons, A Rosenthal
&amp; D L Shelton</p>
]]></content:encoded>
<dc:title>CGRP function-blocking antibodies inhibit neurogenic vasodilatation without affecting heart rate or arterial blood pressure in the rat</dc:title>
<dc:creator>J Zeller</dc:creator>
<dc:creator>K T Poulsen</dc:creator>
<dc:creator>J E Sutton</dc:creator>
<dc:creator>Y N Abdiche</dc:creator>
<dc:creator>S Collier</dc:creator>
<dc:creator>R Chopra</dc:creator>
<dc:creator>C A Garcia</dc:creator>
<dc:creator>J Pons</dc:creator>
<dc:creator>A Rosenthal</dc:creator>
<dc:creator>D L Shelton</dc:creator>
<dc:identifier>doi:10.1038/bjp.2008.334</dc:identifier>
<dc:source>British Journal of Pharmacology advance online publication, September 8, 2008</dc:source>
<dc:date>September 8, 2008</dc:date>
<prism:publicationName>British Journal of Pharmacology</prism:publicationName>
<prism:publicationDate>September 8, 2008</prism:publicationDate>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/bjp.2008.354">
<title>Slow delayed rectifier K&#43; current block by HMR 1556 increases dispersion of repolarization and promotes Torsades de Pointes in rabbit ventricles</title>
<link>http://dx.doi.org/10.1038/bjp.2008.354</link>
<content:encoded><![CDATA[

<p>
<b>Slow delayed rectifier K&#43; current block by HMR 1556 increases dispersion of repolarization and promotes Torsades de Pointes in rabbit ventricles</b>
</p>
<p>British Journal of Pharmacology advance online publication, October 6, 2008. <a href="http://dx.doi.org/10.1038/bjp.2008.354">doi:10.1038/bjp.2008.354</a>
</p>
<p>Authors: P P-S So, P H Backx
&amp; P Dorian</p>
]]></content:encoded>
<dc:title>Slow delayed rectifier K&#43; current block by HMR 1556 increases dispersion of repolarization and promotes Torsades de Pointes in rabbit ventricles</dc:title>
<dc:creator>P P-S So</dc:creator>
<dc:creator>P H Backx</dc:creator>
<dc:creator>P Dorian</dc:creator>
<dc:identifier>doi:10.1038/bjp.2008.354</dc:identifier>
<dc:source>British Journal of Pharmacology advance online publication, October 6, 2008</dc:source>
<dc:date>October 6, 2008</dc:date>
<prism:publicationName>British Journal of Pharmacology</prism:publicationName>
<prism:publicationDate>October 6, 2008</prism:publicationDate>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/bjp.2008.327">
<title>Diabetic state, high plasma insulin and angiotensin II combine to augment endothelin-1-induced vasoconstriction via ETA receptors and ERK</title>
<link>http://dx.doi.org/10.1038/bjp.2008.327</link>
<content:encoded><![CDATA[

<p>
<b>Diabetic state, high plasma insulin and angiotensin II combine to augment endothelin-1-induced vasoconstriction via ETA receptors and ERK</b>
</p>
<p>British Journal of Pharmacology advance online publication, August 18, 2008. <a href="http://dx.doi.org/10.1038/bjp.2008.327">doi:10.1038/bjp.2008.327</a>
</p>
<p>Authors: T Kobayashi, T Nogami, K Taguchi, T Matsumoto
&amp; K Kamata</p>
]]></content:encoded>
<dc:title>Diabetic state, high plasma insulin and angiotensin II combine to augment endothelin-1-induced vasoconstriction via ETA receptors and ERK</dc:title>
<dc:creator>T Kobayashi</dc:creator>
<dc:creator>T Nogami</dc:creator>
<dc:creator>K Taguchi</dc:creator>
<dc:creator>T Matsumoto</dc:creator>
<dc:creator>K Kamata</dc:creator>
<dc:identifier>doi:10.1038/bjp.2008.327</dc:identifier>
<dc:source>British Journal of Pharmacology advance online publication, August 18, 2008</dc:source>
<dc:date>August 18, 2008</dc:date>
<prism:publicationName>British Journal of Pharmacology</prism:publicationName>
<prism:publicationDate>August 18, 2008</prism:publicationDate>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/bjp.2008.374">
<title>Hot target on nociceptors: perspectives, caveats and unique features</title>
<link>http://dx.doi.org/10.1038/bjp.2008.374</link>
<content:encoded><![CDATA[

<p>
<b>Hot target on nociceptors: perspectives, caveats and unique features</b>
</p>
<p>British Journal of Pharmacology advance online publication, November 10, 2008. <a href="http://dx.doi.org/10.1038/bjp.2008.374">doi:10.1038/bjp.2008.374</a>
</p>
<p>Author: J Szolcs&#225;nyi</p>
]]></content:encoded>
<dc:title>Hot target on nociceptors: perspectives, caveats and unique features</dc:title>
<dc:creator>J Szolcs&#225;nyi</dc:creator>
<dc:identifier>doi:10.1038/bjp.2008.374</dc:identifier>
<dc:source>British Journal of Pharmacology advance online publication, November 10, 2008</dc:source>
<dc:date>November 10, 2008</dc:date>
<prism:publicationName>British Journal of Pharmacology</prism:publicationName>
<prism:publicationDate>November 10, 2008</prism:publicationDate>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/bjp.2008.347">
<title>Pleiotropic action(s) of the bradycardic agent ivabradine: cardiovascular protection beyond heart rate reduction</title>
<link>http://dx.doi.org/10.1038/bjp.2008.347</link>
<content:encoded><![CDATA[

<p>
<b>Pleiotropic action(s) of the bradycardic agent ivabradine: cardiovascular protection beyond heart rate reduction</b>
</p>
<p>British Journal of Pharmacology advance online publication, September 1, 2008. <a href="http://dx.doi.org/10.1038/bjp.2008.347">doi:10.1038/bjp.2008.347</a>
</p>
<p>Author: G Heusch</p>
]]></content:encoded>
<dc:title>Pleiotropic action(s) of the bradycardic agent ivabradine: cardiovascular protection beyond heart rate reduction</dc:title>
<dc:creator>G Heusch</dc:creator>
<dc:identifier>doi:10.1038/bjp.2008.347</dc:identifier>
<dc:source>British Journal of Pharmacology advance online publication, September 1, 2008</dc:source>
<dc:date>September 1, 2008</dc:date>
<prism:publicationName>British Journal of Pharmacology</prism:publicationName>
<prism:publicationDate>September 1, 2008</prism:publicationDate>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/bjp.2008.365">
<title>Intra- and extrarenal arteries exhibit different profiles of contractile responses in high glucose conditions</title>
<link>http://dx.doi.org/10.1038/bjp.2008.365</link>
<content:encoded><![CDATA[

<p>
<b>Intra- and extrarenal arteries exhibit different profiles of contractile responses in high glucose conditions</b>
</p>
<p>British Journal of Pharmacology advance online publication, September 22, 2008. <a href="http://dx.doi.org/10.1038/bjp.2008.365">doi:10.1038/bjp.2008.365</a>
</p>
<p>Authors: K Nobe, Y Nezu, N Tsumita, T Hashimoto
&amp; K Honda</p>
]]></content:encoded>
<dc:title>Intra- and extrarenal arteries exhibit different profiles of contractile responses in high glucose conditions</dc:title>
<dc:creator>K Nobe</dc:creator>
<dc:creator>Y Nezu</dc:creator>
<dc:creator>N Tsumita</dc:creator>
<dc:creator>T Hashimoto</dc:creator>
<dc:creator>K Honda</dc:creator>
<dc:identifier>doi:10.1038/bjp.2008.365</dc:identifier>
<dc:source>British Journal of Pharmacology advance online publication, September 22, 2008</dc:source>
<dc:date>September 22, 2008</dc:date>
<prism:publicationName>British Journal of Pharmacology</prism:publicationName>
<prism:publicationDate>September 22, 2008</prism:publicationDate>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/bjp.2008.330">
<title>trans-Resveratrol, an extract of red wine, inhibits human eosinophil activation and degranulation</title>
<link>http://dx.doi.org/10.1038/bjp.2008.330</link>
<content:encoded><![CDATA[

<p>
<b>trans-Resveratrol, an extract of red wine, inhibits human eosinophil activation and degranulation</b>
</p>
<p>British Journal of Pharmacology advance online publication, September 8, 2008. <a href="http://dx.doi.org/10.1038/bjp.2008.330">doi:10.1038/bjp.2008.330</a>
</p>
<p>Authors: Y Tan
&amp; L H K Lim</p>
]]></content:encoded>
<dc:title>trans-Resveratrol, an extract of red wine, inhibits human eosinophil activation and degranulation</dc:title>
<dc:creator>Y Tan</dc:creator>
<dc:creator>L H K Lim</dc:creator>
<dc:identifier>doi:10.1038/bjp.2008.330</dc:identifier>
<dc:source>British Journal of Pharmacology advance online publication, September 8, 2008</dc:source>
<dc:date>September 8, 2008</dc:date>
<prism:publicationName>British Journal of Pharmacology</prism:publicationName>
<prism:publicationDate>September 8, 2008</prism:publicationDate>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/bjp.2008.341">
<title>Dexmedetomidine and ST-91 analgesia in the formalin model is mediated by &#945;2A-adrenoceptors: a mechanism of action distinct from morphine</title>
<link>http://dx.doi.org/10.1038/bjp.2008.341</link>
<content:encoded><![CDATA[

<p>
<b>Dexmedetomidine and ST-91 analgesia in the formalin model is mediated by &#945;2A-adrenoceptors: a mechanism of action distinct from morphine</b>
</p>
<p>British Journal of Pharmacology advance online publication, September 1, 2008. <a href="http://dx.doi.org/10.1038/bjp.2008.341">doi:10.1038/bjp.2008.341</a>
</p>
<p>Authors: A Nazarian, C A Christianson, X-Y Hua
&amp; T L Yaksh</p>
]]></content:encoded>
<dc:title>Dexmedetomidine and ST-91 analgesia in the formalin model is mediated by &#945;2A-adrenoceptors: a mechanism of action distinct from morphine</dc:title>
<dc:creator>A Nazarian</dc:creator>
<dc:creator>C A Christianson</dc:creator>
<dc:creator>X-Y Hua</dc:creator>
<dc:creator>T L Yaksh</dc:creator>
<dc:identifier>doi:10.1038/bjp.2008.341</dc:identifier>
<dc:source>British Journal of Pharmacology advance online publication, September 1, 2008</dc:source>
<dc:date>September 1, 2008</dc:date>
<prism:publicationName>British Journal of Pharmacology</prism:publicationName>
<prism:publicationDate>September 1, 2008</prism:publicationDate>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/bjp.2008.370">
<title>Mono-galloyl glucose derivatives are potent poly(ADP-ribose) glycohydrolase (PARG) inhibitors and partially reduce PARP-1-dependent cell death</title>
<link>http://dx.doi.org/10.1038/bjp.2008.370</link>
<content:encoded><![CDATA[

<p>
<b>Mono-galloyl glucose derivatives are potent poly(ADP-ribose) glycohydrolase (PARG) inhibitors and partially reduce PARP-1-dependent cell death</b>
</p>
<p>British Journal of Pharmacology advance online publication, September 22, 2008. <a href="http://dx.doi.org/10.1038/bjp.2008.370">doi:10.1038/bjp.2008.370</a>
</p>
<p>Authors: L Formentini, P Arapistas, M Pittelli, M Jacomelli, V Pitozzi, S Menichetti, A Romani, L Giovannelli, F Moroni
&amp; A Chiarugi</p>
]]></content:encoded>
<dc:title>Mono-galloyl glucose derivatives are potent poly(ADP-ribose) glycohydrolase (PARG) inhibitors and partially reduce PARP-1-dependent cell death</dc:title>
<dc:creator>L Formentini</dc:creator>
<dc:creator>P Arapistas</dc:creator>
<dc:creator>M Pittelli</dc:creator>
<dc:creator>M Jacomelli</dc:creator>
<dc:creator>V Pitozzi</dc:creator>
<dc:creator>S Menichetti</dc:creator>
<dc:creator>A Romani</dc:creator>
<dc:creator>L Giovannelli</dc:creator>
<dc:creator>F Moroni</dc:creator>
<dc:creator>A Chiarugi</dc:creator>
<dc:identifier>doi:10.1038/bjp.2008.370</dc:identifier>
<dc:source>British Journal of Pharmacology advance online publication, September 22, 2008</dc:source>
<dc:date>September 22, 2008</dc:date>
<prism:publicationName>British Journal of Pharmacology</prism:publicationName>
<prism:publicationDate>September 22, 2008</prism:publicationDate>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/bjp.2008.363">
<title>The guinea-pig tracheal potential difference as an in vivo model for the study of epithelial sodium channel function in the airways</title>
<link>http://dx.doi.org/10.1038/bjp.2008.363</link>
<content:encoded><![CDATA[

<p>
<b>The guinea-pig tracheal potential difference as an in vivo model for the study of epithelial sodium channel function in the airways</b>
</p>
<p>British Journal of Pharmacology advance online publication, September 22, 2008. <a href="http://dx.doi.org/10.1038/bjp.2008.363">doi:10.1038/bjp.2008.363</a>
</p>
<p>Authors: K J Coote, H Atherton, A Young, R Sugar, R Burrows, N J Smith, J-M Schlaeppi, P J Groot-Kormelink, M Gosling
&amp; H Danahay</p>
]]></content:encoded>
<dc:title>The guinea-pig tracheal potential difference as an in vivo model for the study of epithelial sodium channel function in the airways</dc:title>
<dc:creator>K J Coote</dc:creator>
<dc:creator>H Atherton</dc:creator>
<dc:creator>A Young</dc:creator>
<dc:creator>R Sugar</dc:creator>
<dc:creator>R Burrows</dc:creator>
<dc:creator>N J Smith</dc:creator>
<dc:creator>J-M Schlaeppi</dc:creator>
<dc:creator>P J Groot-Kormelink</dc:creator>
<dc:creator>M Gosling</dc:creator>
<dc:creator>H Danahay</dc:creator>
<dc:identifier>doi:10.1038/bjp.2008.363</dc:identifier>
<dc:source>British Journal of Pharmacology advance online publication, September 22, 2008</dc:source>
<dc:date>September 22, 2008</dc:date>
<prism:publicationName>British Journal of Pharmacology</prism:publicationName>
<prism:publicationDate>September 22, 2008</prism:publicationDate>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/bjp.2008.332">
<title>Effects of excitatory and inhibitory neurotransmission on motor patterns of human sigmoid colon in vitro</title>
<link>http://dx.doi.org/10.1038/bjp.2008.332</link>
<content:encoded><![CDATA[

<p>
<b>Effects of excitatory and inhibitory neurotransmission on motor patterns of human sigmoid colon in vitro</b>
</p>
<p>British Journal of Pharmacology advance online publication, September 1, 2008. <a href="http://dx.doi.org/10.1038/bjp.2008.332">doi:10.1038/bjp.2008.332</a>
</p>
<p>Authors: M Aul&#237;, E Mart&#237;nez, D Gallego, A Opazo, F Esp&#237;n, M Mart&#237;-Gallostra, M Jim&#233;nez
&amp; P Clav&#233;</p>
]]></content:encoded>
<dc:title>Effects of excitatory and inhibitory neurotransmission on motor patterns of human sigmoid colon in vitro</dc:title>
<dc:creator>M Aul&#237;</dc:creator>
<dc:creator>E Mart&#237;nez</dc:creator>
<dc:creator>D Gallego</dc:creator>
<dc:creator>A Opazo</dc:creator>
<dc:creator>F Esp&#237;n</dc:creator>
<dc:creator>M Mart&#237;-Gallostra</dc:creator>
<dc:creator>M Jim&#233;nez</dc:creator>
<dc:creator>P Clav&#233;</dc:creator>
<dc:identifier>doi:10.1038/bjp.2008.332</dc:identifier>
<dc:source>British Journal of Pharmacology advance online publication, September 1, 2008</dc:source>
<dc:date>September 1, 2008</dc:date>
<prism:publicationName>British Journal of Pharmacology</prism:publicationName>
<prism:publicationDate>September 1, 2008</prism:publicationDate>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/bjp.2008.343">
<title>Effect of hypouricaemic and hyperuricaemic drugs on the renal urate efflux transporter, multidrug resistance protein 4</title>
<link>http://dx.doi.org/10.1038/bjp.2008.343</link>
<content:encoded><![CDATA[

<p>
<b>Effect of hypouricaemic and hyperuricaemic drugs on the renal urate efflux transporter, multidrug resistance protein 4</b>
</p>
<p>British Journal of Pharmacology advance online publication, August 25, 2008. <a href="http://dx.doi.org/10.1038/bjp.2008.343">doi:10.1038/bjp.2008.343</a>
</p>
<p>Authors: A A K El-Sheikh, J J M W van den Heuvel, J B Koenderink
&amp; F G M Russel</p>
]]></content:encoded>
<dc:title>Effect of hypouricaemic and hyperuricaemic drugs on the renal urate efflux transporter, multidrug resistance protein 4</dc:title>
<dc:creator>A A K El-Sheikh</dc:creator>
<dc:creator>J J M W van den Heuvel</dc:creator>
<dc:creator>J B Koenderink</dc:creator>
<dc:creator>F G M Russel</dc:creator>
<dc:identifier>doi:10.1038/bjp.2008.343</dc:identifier>
<dc:source>British Journal of Pharmacology advance online publication, August 25, 2008</dc:source>
<dc:date>August 25, 2008</dc:date>
<prism:publicationName>British Journal of Pharmacology</prism:publicationName>
<prism:publicationDate>August 25, 2008</prism:publicationDate>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/bjp.2008.369">
<title>Use of atorvastatin as an anti-inflammatory treatment in Crohn's disease</title>
<link>http://dx.doi.org/10.1038/bjp.2008.369</link>
<content:encoded><![CDATA[

<p>
<b>Use of atorvastatin as an anti-inflammatory treatment in Crohn's disease</b>
</p>
<p>British Journal of Pharmacology advance online publication, September 22, 2008. <a href="http://dx.doi.org/10.1038/bjp.2008.369">doi:10.1038/bjp.2008.369</a>
</p>
<p>Authors: O Grip, S Janciauskiene
&amp; A Bredberg</p>
]]></content:encoded>
<dc:title>Use of atorvastatin as an anti-inflammatory treatment in Crohn's disease</dc:title>
<dc:creator>O Grip</dc:creator>
<dc:creator>S Janciauskiene</dc:creator>
<dc:creator>A Bredberg</dc:creator>
<dc:identifier>doi:10.1038/bjp.2008.369</dc:identifier>
<dc:source>British Journal of Pharmacology advance online publication, September 22, 2008</dc:source>
<dc:date>September 22, 2008</dc:date>
<prism:publicationName>British Journal of Pharmacology</prism:publicationName>
<prism:publicationDate>September 22, 2008</prism:publicationDate>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/bjp.2008.367">
<title>An endogenous regulator of inflammation, resolvin E1, modulates osteoclast differentiation and bone resorption</title>
<link>http://dx.doi.org/10.1038/bjp.2008.367</link>
<content:encoded><![CDATA[

<p>
<b>An endogenous regulator of inflammation, resolvin E1, modulates osteoclast differentiation and bone resorption</b>
</p>
<p>British Journal of Pharmacology advance online publication, September 22, 2008. <a href="http://dx.doi.org/10.1038/bjp.2008.367">doi:10.1038/bjp.2008.367</a>
</p>
<p>Authors: B S Herrera, T Ohira, L Gao, K Omori, R Yang, M Zhu, M N Muscara, C N Serhan, T E Van Dyke
&amp; R Gyurko</p>
]]></content:encoded>
<dc:title>An endogenous regulator of inflammation, resolvin E1, modulates osteoclast differentiation and bone resorption</dc:title>
<dc:creator>B S Herrera</dc:creator>
<dc:creator>T Ohira</dc:creator>
<dc:creator>L Gao</dc:creator>
<dc:creator>K Omori</dc:creator>
<dc:creator>R Yang</dc:creator>
<dc:creator>M Zhu</dc:creator>
<dc:creator>M N Muscara</dc:creator>
<dc:creator>C N Serhan</dc:creator>
<dc:creator>T E Van Dyke</dc:creator>
<dc:creator>R Gyurko</dc:creator>
<dc:identifier>doi:10.1038/bjp.2008.367</dc:identifier>
<dc:source>British Journal of Pharmacology advance online publication, September 22, 2008</dc:source>
<dc:date>September 22, 2008</dc:date>
<prism:publicationName>British Journal of Pharmacology</prism:publicationName>
<prism:publicationDate>September 22, 2008</prism:publicationDate>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/bjp.2008.356">
<title>Luteolin inhibits myelin basic protein-induced human mast cell activation and mast cell-dependent stimulation of Jurkat T cells</title>
<link>http://dx.doi.org/10.1038/bjp.2008.356</link>
<content:encoded><![CDATA[

<p>
<b>Luteolin inhibits myelin basic protein-induced human mast cell activation and mast cell-dependent stimulation of Jurkat T cells</b>
</p>
<p>British Journal of Pharmacology advance online publication, September 22, 2008. <a href="http://dx.doi.org/10.1038/bjp.2008.356">doi:10.1038/bjp.2008.356</a>
</p>
<p>Authors: D Kempuraj, M Tagen, B P Iliopoulou, A Clemons, M Vasiadi, W Boucher, M House, A Wolfberg
&amp; T C Theoharides</p>
]]></content:encoded>
<dc:title>Luteolin inhibits myelin basic protein-induced human mast cell activation and mast cell-dependent stimulation of Jurkat T cells</dc:title>
<dc:creator>D Kempuraj</dc:creator>
<dc:creator>M Tagen</dc:creator>
<dc:creator>B P Iliopoulou</dc:creator>
<dc:creator>A Clemons</dc:creator>
<dc:creator>M Vasiadi</dc:creator>
<dc:creator>W Boucher</dc:creator>
<dc:creator>M House</dc:creator>
<dc:creator>A Wolfberg</dc:creator>
<dc:creator>T C Theoharides</dc:creator>
<dc:identifier>doi:10.1038/bjp.2008.356</dc:identifier>
<dc:source>British Journal of Pharmacology advance online publication, September 22, 2008</dc:source>
<dc:date>September 22, 2008</dc:date>
<prism:publicationName>British Journal of Pharmacology</prism:publicationName>
<prism:publicationDate>September 22, 2008</prism:publicationDate>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/bjp.2008.349">
<title>Viral vectors: from virology to transgene expression</title>
<link>http://dx.doi.org/10.1038/bjp.2008.349</link>
<content:encoded><![CDATA[

<p>
<b>Viral vectors: from virology to transgene expression</b>
</p>
<p>British Journal of Pharmacology advance online publication, September 8, 2008. <a href="http://dx.doi.org/10.1038/bjp.2008.349">doi:10.1038/bjp.2008.349</a>
</p>
<p>Authors: D Bouard, N Alazard-Dany
&amp; F-L Cosset</p>
]]></content:encoded>
<dc:title>Viral vectors: from virology to transgene expression</dc:title>
<dc:creator>D Bouard</dc:creator>
<dc:creator>N Alazard-Dany</dc:creator>
<dc:creator>F-L Cosset</dc:creator>
<dc:identifier>doi:10.1038/bjp.2008.349</dc:identifier>
<dc:source>British Journal of Pharmacology advance online publication, September 8, 2008</dc:source>
<dc:date>September 8, 2008</dc:date>
<prism:publicationName>British Journal of Pharmacology</prism:publicationName>
<prism:publicationDate>September 8, 2008</prism:publicationDate>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/bjp.2008.358">
<title>Desensitization of the soluble guanylyl cyclase&#47;cGMP pathway by lipopolysaccharide in rat isolated pulmonary artery but not aorta</title>
<link>http://dx.doi.org/10.1038/bjp.2008.358</link>
<content:encoded><![CDATA[

<p>
<b>Desensitization of the soluble guanylyl cyclase&#47;cGMP pathway by lipopolysaccharide in rat isolated pulmonary artery but not aorta</b>
</p>
<p>British Journal of Pharmacology advance online publication, September 22, 2008. <a href="http://dx.doi.org/10.1038/bjp.2008.358">doi:10.1038/bjp.2008.358</a>
</p>
<p>Authors: M S H El-Awady, S V Smirnov
&amp; M L Watson</p>
]]></content:encoded>
<dc:title>Desensitization of the soluble guanylyl cyclase&#47;cGMP pathway by lipopolysaccharide in rat isolated pulmonary artery but not aorta</dc:title>
<dc:creator>M S H El-Awady</dc:creator>
<dc:creator>S V Smirnov</dc:creator>
<dc:creator>M L Watson</dc:creator>
<dc:identifier>doi:10.1038/bjp.2008.358</dc:identifier>
<dc:source>British Journal of Pharmacology advance online publication, September 22, 2008</dc:source>
<dc:date>September 22, 2008</dc:date>
<prism:publicationName>British Journal of Pharmacology</prism:publicationName>
<prism:publicationDate>September 22, 2008</prism:publicationDate>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/bjp.2008.373">
<title>Protective action of doxycycline against diabetic cardiomyopathy in rats</title>
<link>http://dx.doi.org/10.1038/bjp.2008.373</link>
<content:encoded><![CDATA[

<p>
<b>Protective action of doxycycline against diabetic cardiomyopathy in rats</b>
</p>
<p>British Journal of Pharmacology advance online publication, September 22, 2008. <a href="http://dx.doi.org/10.1038/bjp.2008.373">doi:10.1038/bjp.2008.373</a>
</p>
<p>Authors: N Yaras, M Sariahmetoglu, A Bilginoglu, A Aydemir-Koksoy, A Onay-Besikci, B Turan
&amp; R Schulz</p>
]]></content:encoded>
<dc:title>Protective action of doxycycline against diabetic cardiomyopathy in rats</dc:title>
<dc:creator>N Yaras</dc:creator>
<dc:creator>M Sariahmetoglu</dc:creator>
<dc:creator>A Bilginoglu</dc:creator>
<dc:creator>A Aydemir-Koksoy</dc:creator>
<dc:creator>A Onay-Besikci</dc:creator>
<dc:creator>B Turan</dc:creator>
<dc:creator>R Schulz</dc:creator>
<dc:identifier>doi:10.1038/bjp.2008.373</dc:identifier>
<dc:source>British Journal of Pharmacology advance online publication, September 22, 2008</dc:source>
<dc:date>September 22, 2008</dc:date>
<prism:publicationName>British Journal of Pharmacology</prism:publicationName>
<prism:publicationDate>September 22, 2008</prism:publicationDate>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/bjp.2008.360">
<title>Identification of &#945;1L-adrenoceptor in mice and its abolition by &#945;1A-adrenoceptor gene knockout</title>
<link>http://dx.doi.org/10.1038/bjp.2008.360</link>
<content:encoded><![CDATA[

<p>
<b>Identification of &#945;1L-adrenoceptor in mice and its abolition by &#945;1A-adrenoceptor gene knockout</b>
</p>
<p>British Journal of Pharmacology advance online publication, September 22, 2008. <a href="http://dx.doi.org/10.1038/bjp.2008.360">doi:10.1038/bjp.2008.360</a>
</p>
<p>Authors: I Muramatsu, S Morishima, F Suzuki, H Yoshiki, A S M Anisuzzaman, T Tanaka, M C Rodrigo, B E Myagmar
&amp; P C Simpson</p>
]]></content:encoded>
<dc:title>Identification of &#945;1L-adrenoceptor in mice and its abolition by &#945;1A-adrenoceptor gene knockout</dc:title>
<dc:creator>I Muramatsu</dc:creator>
<dc:creator>S Morishima</dc:creator>
<dc:creator>F Suzuki</dc:creator>
<dc:creator>H Yoshiki</dc:creator>
<dc:creator>A S M Anisuzzaman</dc:creator>
<dc:creator>T Tanaka</dc:creator>
<dc:creator>M C Rodrigo</dc:creator>
<dc:creator>B E Myagmar</dc:creator>
<dc:creator>P C Simpson</dc:creator>
<dc:identifier>doi:10.1038/bjp.2008.360</dc:identifier>
<dc:source>British Journal of Pharmacology advance online publication, September 22, 2008</dc:source>
<dc:date>September 22, 2008</dc:date>
<prism:publicationName>British Journal of Pharmacology</prism:publicationName>
<prism:publicationDate>September 22, 2008</prism:publicationDate>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/bjp.2008.335">
<title>Inhibition of fatty acid amide hydrolase produces PPAR-&#945;-mediated analgesia in a rat model of inflammatory pain</title>
<link>http://dx.doi.org/10.1038/bjp.2008.335</link>
<content:encoded><![CDATA[

<p>
<b>Inhibition of fatty acid amide hydrolase produces PPAR-&#945;-mediated analgesia in a rat model of inflammatory pain</b>
</p>
<p>British Journal of Pharmacology advance online publication, August 25, 2008. <a href="http://dx.doi.org/10.1038/bjp.2008.335">doi:10.1038/bjp.2008.335</a>
</p>
<p>Authors: D R Sagar, D A Kendall
&amp; V Chapman</p>
]]></content:encoded>
<dc:title>Inhibition of fatty acid amide hydrolase produces PPAR-&#945;-mediated analgesia in a rat model of inflammatory pain</dc:title>
<dc:creator>D R Sagar</dc:creator>
<dc:creator>D A Kendall</dc:creator>
<dc:creator>V Chapman</dc:creator>
<dc:identifier>doi:10.1038/bjp.2008.335</dc:identifier>
<dc:source>British Journal of Pharmacology advance online publication, August 25, 2008</dc:source>
<dc:date>August 25, 2008</dc:date>
<prism:publicationName>British Journal of Pharmacology</prism:publicationName>
<prism:publicationDate>August 25, 2008</prism:publicationDate>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/bjp.2008.355">
<title>Central muscarinic receptor subtypes involved in pilocarpine-induced salivation, hypertension and water intake</title>
<link>http://dx.doi.org/10.1038/bjp.2008.355</link>
<content:encoded><![CDATA[

<p>
<b>Central muscarinic receptor subtypes involved in pilocarpine-induced salivation, hypertension and water intake</b>
</p>
<p>British Journal of Pharmacology advance online publication, September 29, 2008. <a href="http://dx.doi.org/10.1038/bjp.2008.355">doi:10.1038/bjp.2008.355</a>
</p>
<p>Authors: T L Borella, L A De Luca, D S A Colombari
&amp; J V Menani</p>
]]></content:encoded>
<dc:title>Central muscarinic receptor subtypes involved in pilocarpine-induced salivation, hypertension and water intake</dc:title>
<dc:creator>T L Borella</dc:creator>
<dc:creator>L A De Luca</dc:creator>
<dc:creator>D S A Colombari</dc:creator>
<dc:creator>J V Menani</dc:creator>
<dc:identifier>doi:10.1038/bjp.2008.355</dc:identifier>
<dc:source>British Journal of Pharmacology advance online publication, September 29, 2008</dc:source>
<dc:date>September 29, 2008</dc:date>
<prism:publicationName>British Journal of Pharmacology</prism:publicationName>
<prism:publicationDate>September 29, 2008</prism:publicationDate>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/bjp.2008.375">
<title>Activation of the transient receptor potential vanilloid-1 (TRPV1) channel opens the gate for pain relief</title>
<link>http://dx.doi.org/10.1038/bjp.2008.375</link>
<content:encoded><![CDATA[

<p>
<b>Activation of the transient receptor potential vanilloid-1 (TRPV1) channel opens the gate for pain relief</b>
</p>
<p>British Journal of Pharmacology advance online publication, November 10, 2008. <a href="http://dx.doi.org/10.1038/bjp.2008.375">doi:10.1038/bjp.2008.375</a>
</p>
<p>Authors: G Jancs&#243;, M Dux, O Oszl&#225;cs
&amp; P S&#225;ntha</p>
]]></content:encoded>
<dc:title>Activation of the transient receptor potential vanilloid-1 (TRPV1) channel opens the gate for pain relief</dc:title>
<dc:creator>G Jancs&#243;</dc:creator>
<dc:creator>M Dux</dc:creator>
<dc:creator>O Oszl&#225;cs</dc:creator>
<dc:creator>P S&#225;ntha</dc:creator>
<dc:identifier>doi:10.1038/bjp.2008.375</dc:identifier>
<dc:source>British Journal of Pharmacology advance online publication, November 10, 2008</dc:source>
<dc:date>November 10, 2008</dc:date>
<prism:publicationName>British Journal of Pharmacology</prism:publicationName>
<prism:publicationDate>November 10, 2008</prism:publicationDate>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/bjp.2008.344">
<title>Peroxynitrite decreases arrhythmias induced by ischaemia reperfusion in anaesthetized dogs, without involving mitochondrial KATP channels</title>
<link>http://dx.doi.org/10.1038/bjp.2008.344</link>
<content:encoded><![CDATA[

<p>
<b>Peroxynitrite decreases arrhythmias induced by ischaemia reperfusion in anaesthetized dogs, without involving mitochondrial KATP channels</b>
</p>
<p>British Journal of Pharmacology advance online publication, September 1, 2008. <a href="http://dx.doi.org/10.1038/bjp.2008.344">doi:10.1038/bjp.2008.344</a>
</p>
<p>Authors: A Kiss, L Juh&#225;sz, I Huli&#225;k
&amp; &#193; V&#233;gh</p>
]]></content:encoded>
<dc:title>Peroxynitrite decreases arrhythmias induced by ischaemia reperfusion in anaesthetized dogs, without involving mitochondrial KATP channels</dc:title>
<dc:creator>A Kiss</dc:creator>
<dc:creator>L Juh&#225;sz</dc:creator>
<dc:creator>I Huli&#225;k</dc:creator>
<dc:creator>&#193; V&#233;gh</dc:creator>
<dc:identifier>doi:10.1038/bjp.2008.344</dc:identifier>
<dc:source>British Journal of Pharmacology advance online publication, September 1, 2008</dc:source>
<dc:date>September 1, 2008</dc:date>
<prism:publicationName>British Journal of Pharmacology</prism:publicationName>
<prism:publicationDate>September 1, 2008</prism:publicationDate>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/bjp.2008.337">
<title>Endogenous and synthetic agonists of GPR119 differ in signalling pathways and their effects on insulin secretion in MIN6c4 insulinoma cells</title>
<link>http://dx.doi.org/10.1038/bjp.2008.337</link>
<content:encoded><![CDATA[

<p>
<b>Endogenous and synthetic agonists of GPR119 differ in signalling pathways and their effects on insulin secretion in MIN6c4 insulinoma cells</b>
</p>
<p>British Journal of Pharmacology advance online publication, August 25, 2008. <a href="http://dx.doi.org/10.1038/bjp.2008.337">doi:10.1038/bjp.2008.337</a>
</p>
<p>Authors: Y Ning, K O'Neill, H Lan, L Pang, L X Shan, B E Hawes
&amp; J A Hedrick</p>
]]></content:encoded>
<dc:title>Endogenous and synthetic agonists of GPR119 differ in signalling pathways and their effects on insulin secretion in MIN6c4 insulinoma cells</dc:title>
<dc:creator>Y Ning</dc:creator>
<dc:creator>K O'Neill</dc:creator>
<dc:creator>H Lan</dc:creator>
<dc:creator>L Pang</dc:creator>
<dc:creator>L X Shan</dc:creator>
<dc:creator>B E Hawes</dc:creator>
<dc:creator>J A Hedrick</dc:creator>
<dc:identifier>doi:10.1038/bjp.2008.337</dc:identifier>
<dc:source>British Journal of Pharmacology advance online publication, August 25, 2008</dc:source>
<dc:date>August 25, 2008</dc:date>
<prism:publicationName>British Journal of Pharmacology</prism:publicationName>
<prism:publicationDate>August 25, 2008</prism:publicationDate>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/bjp.2008.357">
<title>Differential role of tachykinin NK3 receptors on cholinergic excitatory neurotransmission in the mouse stomach and small intestine</title>
<link>http://dx.doi.org/10.1038/bjp.2008.357</link>
<content:encoded><![CDATA[

<p>
<b>Differential role of tachykinin NK3 receptors on cholinergic excitatory neurotransmission in the mouse stomach and small intestine</b>
</p>
<p>British Journal of Pharmacology advance online publication, September 22, 2008. <a href="http://dx.doi.org/10.1038/bjp.2008.357">doi:10.1038/bjp.2008.357</a>
</p>
<p>Authors: J G De Man, B Y De Winter, H U De Schepper, A G Herman
&amp; P A Pelckmans</p>
]]></content:encoded>
<dc:title>Differential role of tachykinin NK3 receptors on cholinergic excitatory neurotransmission in the mouse stomach and small intestine</dc:title>
<dc:creator>J G De Man</dc:creator>
<dc:creator>B Y De Winter</dc:creator>
<dc:creator>H U De Schepper</dc:creator>
<dc:creator>A G Herman</dc:creator>
<dc:creator>P A Pelckmans</dc:creator>
<dc:identifier>doi:10.1038/bjp.2008.357</dc:identifier>
<dc:source>British Journal of Pharmacology advance online publication, September 22, 2008</dc:source>
<dc:date>September 22, 2008</dc:date>
<prism:publicationName>British Journal of Pharmacology</prism:publicationName>
<prism:publicationDate>September 22, 2008</prism:publicationDate>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/bjp.2008.326">
<title>H2S-donating sildenafil (ACS6) inhibits superoxide formation and gp91phox expression in arterial endothelial cells: role of protein kinases A and G</title>
<link>http://dx.doi.org/10.1038/bjp.2008.326</link>
<content:encoded><![CDATA[

<p>
<b>H2S-donating sildenafil (ACS6) inhibits superoxide formation and gp91phox expression in arterial endothelial cells: role of protein kinases A and G</b>
</p>
<p>British Journal of Pharmacology advance online publication, September 1, 2008. <a href="http://dx.doi.org/10.1038/bjp.2008.326">doi:10.1038/bjp.2008.326</a>
</p>
<p>Authors: S Muzaffar, J Y Jeremy, A Sparatore, P Del Soldato, G D Angelini
&amp; N Shukla</p>
]]></content:encoded>
<dc:title>H2S-donating sildenafil (ACS6) inhibits superoxide formation and gp91phox expression in arterial endothelial cells: role of protein kinases A and G</dc:title>
<dc:creator>S Muzaffar</dc:creator>
<dc:creator>J Y Jeremy</dc:creator>
<dc:creator>A Sparatore</dc:creator>
<dc:creator>P Del Soldato</dc:creator>
<dc:creator>G D Angelini</dc:creator>
<dc:creator>N Shukla</dc:creator>
<dc:identifier>doi:10.1038/bjp.2008.326</dc:identifier>
<dc:source>British Journal of Pharmacology advance online publication, September 1, 2008</dc:source>
<dc:date>September 1, 2008</dc:date>
<prism:publicationName>British Journal of Pharmacology</prism:publicationName>
<prism:publicationDate>September 1, 2008</prism:publicationDate>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/bjp.2008.351">
<title>The pharmacological challenge to tame the transient receptor potential vanilloid-1 (TRPV1) nocisensor</title>
<link>http://dx.doi.org/10.1038/bjp.2008.351</link>
<content:encoded><![CDATA[

<p>
<b>The pharmacological challenge to tame the transient receptor potential vanilloid-1 (TRPV1) nocisensor</b>
</p>
<p>British Journal of Pharmacology advance online publication, September 22, 2008. <a href="http://dx.doi.org/10.1038/bjp.2008.351">doi:10.1038/bjp.2008.351</a>
</p>
<p>Author: P Holzer</p>
]]></content:encoded>
<dc:title>The pharmacological challenge to tame the transient receptor potential vanilloid-1 (TRPV1) nocisensor</dc:title>
<dc:creator>P Holzer</dc:creator>
<dc:identifier>doi:10.1038/bjp.2008.351</dc:identifier>
<dc:source>British Journal of Pharmacology advance online publication, September 22, 2008</dc:source>
<dc:date>September 22, 2008</dc:date>
<prism:publicationName>British Journal of Pharmacology</prism:publicationName>
<prism:publicationDate>September 22, 2008</prism:publicationDate>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/bjp.2008.371">
<title>Virodhamine relaxes the human pulmonary artery through the endothelial cannabinoid receptor and indirectly through a COX product</title>
<link>http://dx.doi.org/10.1038/bjp.2008.371</link>
<content:encoded><![CDATA[

<p>
<b>Virodhamine relaxes the human pulmonary artery through the endothelial cannabinoid receptor and indirectly through a COX product</b>
</p>
<p>British Journal of Pharmacology advance online publication, September 22, 2008. <a href="http://dx.doi.org/10.1038/bjp.2008.371">doi:10.1038/bjp.2008.371</a>
</p>
<p>Authors: H Koz&#322;owska, M Baranowska, E Schlicker, M Koz&#322;owski, J Lauda&#241;ski
&amp; B Malinowska</p>
]]></content:encoded>
<dc:title>Virodhamine relaxes the human pulmonary artery through the endothelial cannabinoid receptor and indirectly through a COX product</dc:title>
<dc:creator>H Koz&#322;owska</dc:creator>
<dc:creator>M Baranowska</dc:creator>
<dc:creator>E Schlicker</dc:creator>
<dc:creator>M Koz&#322;owski</dc:creator>
<dc:creator>J Lauda&#241;ski</dc:creator>
<dc:creator>B Malinowska</dc:creator>
<dc:identifier>doi:10.1038/bjp.2008.371</dc:identifier>
<dc:source>British Journal of Pharmacology advance online publication, September 22, 2008</dc:source>
<dc:date>September 22, 2008</dc:date>
<prism:publicationName>British Journal of Pharmacology</prism:publicationName>
<prism:publicationDate>September 22, 2008</prism:publicationDate>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/bjp.2008.340">
<title>MDA7: a novel selective agonist for CB2 receptors that prevents allodynia in rat neuropathic pain models</title>
<link>http://dx.doi.org/10.1038/bjp.2008.340</link>
<content:encoded><![CDATA[

<p>
<b>MDA7: a novel selective agonist for CB2 receptors that prevents allodynia in rat neuropathic pain models</b>
</p>
<p>British Journal of Pharmacology advance online publication, September 1, 2008. <a href="http://dx.doi.org/10.1038/bjp.2008.340">doi:10.1038/bjp.2008.340</a>
</p>
<p>Authors: M Naguib, P Diaz, J J Xu, F Astruc-Diaz, S Craig, P Vivas-Mejia
&amp; D L Brown</p>
]]></content:encoded>
<dc:title>MDA7: a novel selective agonist for CB2 receptors that prevents allodynia in rat neuropathic pain models</dc:title>
<dc:creator>M Naguib</dc:creator>
<dc:creator>P Diaz</dc:creator>
<dc:creator>J J Xu</dc:creator>
<dc:creator>F Astruc-Diaz</dc:creator>
<dc:creator>S Craig</dc:creator>
<dc:creator>P Vivas-Mejia</dc:creator>
<dc:creator>D L Brown</dc:creator>
<dc:identifier>doi:10.1038/bjp.2008.340</dc:identifier>
<dc:source>British Journal of Pharmacology advance online publication, September 1, 2008</dc:source>
<dc:date>September 1, 2008</dc:date>
<prism:publicationName>British Journal of Pharmacology</prism:publicationName>
<prism:publicationDate>September 1, 2008</prism:publicationDate>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/bjp.2008.353">
<title>Low doses of &#945;2-adrenoceptor antagonists augment spinal morphine analgesia and inhibit development of acute and chronic tolerance</title>
<link>http://dx.doi.org/10.1038/bjp.2008.353</link>
<content:encoded><![CDATA[

<p>
<b>Low doses of &#945;2-adrenoceptor antagonists augment spinal morphine analgesia and inhibit development of acute and chronic tolerance</b>
</p>
<p>British Journal of Pharmacology advance online publication, September 22, 2008. <a href="http://dx.doi.org/10.1038/bjp.2008.353">doi:10.1038/bjp.2008.353</a>
</p>
<p>Authors: B Milne, M Sutak, C M Cahill
&amp; K Jhamandas</p>
]]></content:encoded>
<dc:title>Low doses of &#945;2-adrenoceptor antagonists augment spinal morphine analgesia and inhibit development of acute and chronic tolerance</dc:title>
<dc:creator>B Milne</dc:creator>
<dc:creator>M Sutak</dc:creator>
<dc:creator>C M Cahill</dc:creator>
<dc:creator>K Jhamandas</dc:creator>
<dc:identifier>doi:10.1038/bjp.2008.353</dc:identifier>
<dc:source>British Journal of Pharmacology advance online publication, September 22, 2008</dc:source>
<dc:date>September 22, 2008</dc:date>
<prism:publicationName>British Journal of Pharmacology</prism:publicationName>
<prism:publicationDate>September 22, 2008</prism:publicationDate>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
</rdf:RDF>
